Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.31 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22156842 | 0.96 | KIF11 (0.34) | KIF11CSNK1DCSNK1G2 | |
| SCHEMBL22156846 | 0.95 | KIF11 (0.35) | KIF11RORCCSNK1DCSNK1G2HTR1D | |
| SCHEMBL22156845 | 0.94 | KIF11 (0.35) | KIF11RORCCSNK1DCSNK1G2 | |
| SCHEMBL22156840 | 0.93 | RORC (0.35) | KIF11RORCCSNK1DCSNK1G2HTR1D | |
| SCHEMBL23348329 | 0.91 | EGLN2 (0.33) | KIF11RORCCSNK1DCSNK1G2HTR1D | |
| SCHEMBL23348408 | 0.91 | KIF11 (0.35) | KIF11 | |
| SCHEMBL23348406 | 0.86 | KIF11 (0.36) | KIF11RORCCSNK1DCSNK1G2HTR1D | |
| SCHEMBL22156444 | 0.84 | KIF11 (0.36) | KIF11CSNK1DCSNK1G2 | |
| SCHEMBL23348383 | 0.84 | KIF11 (0.38) | KIF11CSNK1D | |
| SCHEMBL23348327 | 0.84 | KIF11 (0.35) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-9527885-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CCND2, CCND1, CRY1 | KIF11 1724/4885RORC 1165/4885CSNK1D 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.